Industry Research Reports

Home > Reports > Service & Software > Respiratory Syncytial Virus (RSV) Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Respiratory Syncytial Virus (RSV) Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-21

Pages: 107 Pages

Report ld: 4142683

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Respiratory Syncytial Virus (RSV) Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus (RSV) Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Respiratory Syncytial Virus (RSV) Testing by region & country, by Type, and by Application.

The Respiratory Syncytial Virus (RSV) Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus (RSV) Testing.

MARKET SEGMENTATION

By Company

BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Testing Services
Testing Kits
Others

Segment by Application

Hospitals
POCT
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Respiratory Syncytial Virus (RSV) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Respiratory Syncytial Virus (RSV) Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Respiratory Syncytial Virus (RSV) Testing in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Respiratory Syncytial Virus (RSV) Testing Product Introduction

1.2 Global Respiratory Syncytial Virus (RSV) Testing Market Size Forecast (2020-2031)

1.3 Respiratory Syncytial Virus (RSV) Testing Market Trends & Drivers

1.3.1 Respiratory Syncytial Virus (RSV) Testing Industry Trends

1.3.2 Respiratory Syncytial Virus (RSV) Testing Market Drivers & Opportunity

1.3.3 Respiratory Syncytial Virus (RSV) Testing Market Challenges

1.3.4 Respiratory Syncytial Virus (RSV) Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Respiratory Syncytial Virus (RSV) Testing Players Revenue Ranking (2024)

2.2 Global Respiratory Syncytial Virus (RSV) Testing Revenue by Company (2020-2025)

2.3 Key Companies Respiratory Syncytial Virus (RSV) Testing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Respiratory Syncytial Virus (RSV) Testing Product Offered

2.5 Key Companies Time to Begin Mass Production of Respiratory Syncytial Virus (RSV) Testing

2.6 Respiratory Syncytial Virus (RSV) Testing Market Competitive Analysis

2.6.1 Respiratory Syncytial Virus (RSV) Testing Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Respiratory Syncytial Virus (RSV) Testing Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus (RSV) Testing as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Testing Services

3.1.2 Testing Kits

3.1.3 Others

3.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type

3.2.1 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value, by Type (2020-2031)

3.2.3 Global Respiratory Syncytial Virus (RSV) Testing Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 POCT

4.1.3 Others

4.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application

4.2.1 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value, by Application (2020-2031)

4.2.3 Global Respiratory Syncytial Virus (RSV) Testing Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region

5.1.1 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2020-2025)

5.1.3 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2026-2031)

5.1.4 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

5.2.2 North America Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

5.3.2 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

5.4.2 Asia Pacific Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

5.5.2 South America Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

5.6.2 Middle East & Africa Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

6.3 United States

6.3.1 United States Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

6.3.2 United States Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

6.4.2 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

6.5.2 China Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

6.5.3 China Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

6.6.2 Japan Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

6.7.2 South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

6.8.2 Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020-2031

6.9.2 India Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

6.9.3 India Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 BD

7.1.1 BD Profile

7.1.2 BD Main Business

7.1.3 BD Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.1.4 BD Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.1.5 BD Recent Developments

7.2 Abbot (Alere)

7.2.1 Abbot (Alere) Profile

7.2.2 Abbot (Alere) Main Business

7.2.3 Abbot (Alere) Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.2.4 Abbot (Alere) Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.2.5 Abbot (Alere) Recent Developments

7.3 Quidel

7.3.1 Quidel Profile

7.3.2 Quidel Main Business

7.3.3 Quidel Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.3.4 Quidel Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.3.5 Quidel Recent Developments

7.4 Roche

7.4.1 Roche Profile

7.4.2 Roche Main Business

7.4.3 Roche Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.4.4 Roche Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.4.5 Roche Recent Developments

7.5 Thermo Fisher Scientific

7.5.1 Thermo Fisher Scientific Profile

7.5.2 Thermo Fisher Scientific Main Business

7.5.3 Thermo Fisher Scientific Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.5.4 Thermo Fisher Scientific Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.5.5 Thermo Fisher Scientific Recent Developments

7.6 Meridian Bioscience

7.6.1 Meridian Bioscience Profile

7.6.2 Meridian Bioscience Main Business

7.6.3 Meridian Bioscience Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.6.4 Meridian Bioscience Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.6.5 Meridian Bioscience Recent Developments

7.7 Analytik Jena

7.7.1 Analytik Jena Profile

7.7.2 Analytik Jena Main Business

7.7.3 Analytik Jena Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.7.4 Analytik Jena Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.7.5 Analytik Jena Recent Developments

7.8 Princeton BioMeditech Corporation

7.8.1 Princeton BioMeditech Corporation Profile

7.8.2 Princeton BioMeditech Corporation Main Business

7.8.3 Princeton BioMeditech Corporation Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.8.4 Princeton BioMeditech Corporation Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.8.5 Princeton BioMeditech Corporation Recent Developments

7.9 BioMerieux

7.9.1 BioMerieux Profile

7.9.2 BioMerieux Main Business

7.9.3 BioMerieux Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.9.4 BioMerieux Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.9.5 BioMerieux Recent Developments

7.10 Sekisui Diagnostics

7.10.1 Sekisui Diagnostics Profile

7.10.2 Sekisui Diagnostics Main Business

7.10.3 Sekisui Diagnostics Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.10.4 Sekisui Diagnostics Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.10.5 Sekisui Diagnostics Recent Developments

7.11 Response Biomedical

7.11.1 Response Biomedical Profile

7.11.2 Response Biomedical Main Business

7.11.3 Response Biomedical Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.11.4 Response Biomedical Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.11.5 Response Biomedical Recent Developments

7.12 SA Scientific

7.12.1 SA Scientific Profile

7.12.2 SA Scientific Main Business

7.12.3 SA Scientific Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.12.4 SA Scientific Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.12.5 SA Scientific Recent Developments

7.13 DiaSorin (Focus Diagnostics)

7.13.1 DiaSorin (Focus Diagnostics) Profile

7.13.2 DiaSorin (Focus Diagnostics) Main Business

7.13.3 DiaSorin (Focus Diagnostics) Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.13.4 DiaSorin (Focus Diagnostics) Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2020-2025)

7.13.5 DiaSorin (Focus Diagnostics) Recent Developments

8 Industry Chain Analysis

8.1 Respiratory Syncytial Virus (RSV) Testing Industrial Chain

8.2 Respiratory Syncytial Virus (RSV) Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Respiratory Syncytial Virus (RSV) Testing Sales Model

8.5.2 Sales Channel

8.5.3 Respiratory Syncytial Virus (RSV) Testing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Respiratory Syncytial Virus (RSV) Testing Market Trends

Table 2. Respiratory Syncytial Virus (RSV) Testing Market Drivers & Opportunity

Table 3. Respiratory Syncytial Virus (RSV) Testing Market Challenges

Table 4. Respiratory Syncytial Virus (RSV) Testing Market Restraints

Table 5. Global Respiratory Syncytial Virus (RSV) Testing Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Respiratory Syncytial Virus (RSV) Testing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Respiratory Syncytial Virus (RSV) Testing Product Type

Table 9. Key Companies Time to Begin Mass Production of Respiratory Syncytial Virus (RSV) Testing

Table 10. Global Respiratory Syncytial Virus (RSV) Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus (RSV) Testing as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Respiratory Syncytial Virus (RSV) Testing Sales Market Share in Value by Type (2020-2025)

Table 17. Global Respiratory Syncytial Virus (RSV) Testing Sales Market Share in Value by Type (2026-2031)

Table 18. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Respiratory Syncytial Virus (RSV) Testing Sales Market Share in Value by Application (2020-2025)

Table 22. Global Respiratory Syncytial Virus (RSV) Testing Sales Market Share in Value by Application (2026-2031)

Table 23. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2020-2025) & (%)

Table 27. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value, (2026-2031) & (US$ Million)

Table 31. BD Basic Information List

Table 32. BD Description and Business Overview

Table 33. BD Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 34. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of BD (2020-2025)

Table 35. BD Recent Developments

Table 36. Abbot (Alere) Basic Information List

Table 37. Abbot (Alere) Description and Business Overview

Table 38. Abbot (Alere) Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 39. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Abbot (Alere) (2020-2025)

Table 40. Abbot (Alere) Recent Developments

Table 41. Quidel Basic Information List

Table 42. Quidel Description and Business Overview

Table 43. Quidel Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 44. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Quidel (2020-2025)

Table 45. Quidel Recent Developments

Table 46. Roche Basic Information List

Table 47. Roche Description and Business Overview

Table 48. Roche Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 49. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Roche (2020-2025)

Table 50. Roche Recent Developments

Table 51. Thermo Fisher Scientific Basic Information List

Table 52. Thermo Fisher Scientific Description and Business Overview

Table 53. Thermo Fisher Scientific Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 54. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Thermo Fisher Scientific (2020-2025)

Table 55. Thermo Fisher Scientific Recent Developments

Table 56. Meridian Bioscience Basic Information List

Table 57. Meridian Bioscience Description and Business Overview

Table 58. Meridian Bioscience Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 59. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Meridian Bioscience (2020-2025)

Table 60. Meridian Bioscience Recent Developments

Table 61. Analytik Jena Basic Information List

Table 62. Analytik Jena Description and Business Overview

Table 63. Analytik Jena Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 64. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Analytik Jena (2020-2025)

Table 65. Analytik Jena Recent Developments

Table 66. Princeton BioMeditech Corporation Basic Information List

Table 67. Princeton BioMeditech Corporation Description and Business Overview

Table 68. Princeton BioMeditech Corporation Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 69. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Princeton BioMeditech Corporation (2020-2025)

Table 70. Princeton BioMeditech Corporation Recent Developments

Table 71. BioMerieux Basic Information List

Table 72. BioMerieux Description and Business Overview

Table 73. BioMerieux Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 74. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of BioMerieux (2020-2025)

Table 75. BioMerieux Recent Developments

Table 76. Sekisui Diagnostics Basic Information List

Table 77. Sekisui Diagnostics Description and Business Overview

Table 78. Sekisui Diagnostics Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 79. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Sekisui Diagnostics (2020-2025)

Table 80. Sekisui Diagnostics Recent Developments

Table 81. Response Biomedical Basic Information List

Table 82. Response Biomedical Description and Business Overview

Table 83. Response Biomedical Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 84. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Response Biomedical (2020-2025)

Table 85. Response Biomedical Recent Developments

Table 86. SA Scientific Basic Information List

Table 87. SA Scientific Description and Business Overview

Table 88. SA Scientific Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 89. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of SA Scientific (2020-2025)

Table 90. SA Scientific Recent Developments

Table 91. DiaSorin (Focus Diagnostics) Basic Information List

Table 92. DiaSorin (Focus Diagnostics) Description and Business Overview

Table 93. DiaSorin (Focus Diagnostics) Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 94. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of DiaSorin (Focus Diagnostics) (2020-2025)

Table 95. DiaSorin (Focus Diagnostics) Recent Developments

Table 96. Key Raw Materials Lists

Table 97. Raw Materials Key Suppliers Lists

Table 98. Respiratory Syncytial Virus (RSV) Testing Downstream Customers

Table 99. Respiratory Syncytial Virus (RSV) Testing Distributors List

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Respiratory Syncytial Virus (RSV) Testing Product Picture

Figure 2. Global Respiratory Syncytial Virus (RSV) Testing Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Respiratory Syncytial Virus (RSV) Testing Sales Value (2020-2031) & (US$ Million)

Figure 4. Respiratory Syncytial Virus (RSV) Testing Report Years Considered

Figure 5. Global Respiratory Syncytial Virus (RSV) Testing Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Respiratory Syncytial Virus (RSV) Testing Revenue in 2024

Figure 7. Respiratory Syncytial Virus (RSV) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Testing Services Picture

Figure 9. Testing Kits Picture

Figure 10. Others Picture

Figure 11. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 12. Global Respiratory Syncytial Virus (RSV) Testing Sales Value Market Share by Type, 2024 & 2031

Figure 13. Product Picture of Hospitals

Figure 14. Product Picture of POCT

Figure 15. Product Picture of Others

Figure 16. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global Respiratory Syncytial Virus (RSV) Testing Sales Value Market Share by Application, 2024 & 2031

Figure 18. North America Respiratory Syncytial Virus (RSV) Testing Sales Value (2020-2031) & (US$ Million)

Figure 19. North America Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2024 VS 2031

Figure 20. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 21. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2024 VS 2031

Figure 22. Asia Pacific Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 23. Asia Pacific Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (%), 2024 VS 2031

Figure 24. South America Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 25. South America Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2024 VS 2031

Figure 26. Middle East & Africa Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 27. Middle East & Africa Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2024 VS 2031

Figure 28. Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value (%), (2020-2031)

Figure 29. United States Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 30. United States Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

Figure 31. United States Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2024 VS 2031

Figure 32. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

Figure 34. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2024 VS 2031

Figure 35. China Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 36. China Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

Figure 37. China Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2024 VS 2031

Figure 38. Japan Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 39. Japan Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

Figure 40. Japan Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2024 VS 2031

Figure 41. South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 42. South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

Figure 43. South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2024 VS 2031

Figure 44. Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

Figure 46. Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2024 VS 2031

Figure 47. India Respiratory Syncytial Virus (RSV) Testing Sales Value, (2020-2031) & (US$ Million)

Figure 48. India Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2024 VS 2031

Figure 49. India Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2024 VS 2031

Figure 50. Respiratory Syncytial Virus (RSV) Testing Industrial Chain

Figure 51. Respiratory Syncytial Virus (RSV) Testing Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Respiratory Syncytial Virus (RSV) Testing market? zhanKai

The top companies in the global Respiratory Syncytial Virus (RSV) Testing market are BD、Abbot (Alere)、Quidel.

Related Reports

Respiratory Syncytial Virus (RSV) Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Respiratory Syncytial Virus (RSV) Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 119
USD 3950.00
(Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Market Research Report 2026
The global Respiratory Syncytial Virus (RSV) Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 112
USD 2900.00
(Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Respiratory Syncytial Virus (RSV) Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 137
USD 4900.00
(Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Respiratory Syncytial Virus (RSV) Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 95
USD 4250.00
(Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Market Research Report 2025
The global market for Respiratory Syncytial Virus (RSV) Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 85
USD 2900.00
(Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Market Research Report 2024
The global Respiratory Syncytial Virus (RSV) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-26
Pages: 83
USD 2900.00
(Single User License)
Respiratory Syncytial Virus (RSV) Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Respiratory Syncytial Virus (RSV) Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-14
Pages: 118
USD 3950.00
(Single User License)

Respiratory Syncytial Virus (RSV) Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Respiratory Syncytial Virus (RSV) Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 119
USD 3950.00 (Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Market Research Report 2026
The global Respiratory Syncytial Virus (RSV) Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 112
USD 2900.00 (Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Respiratory Syncytial Virus (RSV) Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 137
USD 4900.00 (Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Respiratory Syncytial Virus (RSV) Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 95
USD 4250.00 (Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Market Research Report 2025
The global market for Respiratory Syncytial Virus (RSV) Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 85
USD 2900.00 (Single User License)
Global Respiratory Syncytial Virus (RSV) Testing Market Research Report 2024
The global Respiratory Syncytial Virus (RSV) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-26
Pages: 83
USD 2900.00 (Single User License)
Respiratory Syncytial Virus (RSV) Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Respiratory Syncytial Virus (RSV) Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-14
Pages: 118
USD 3950.00 (Single User License)